Linscomb & Williams, Inc. Abbott Laboratories Transaction History

Linscomb & Williams, Inc.

$2.01 Billion
Q3 2024

A detailed history of Linscomb & Williams, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 101,458 shares of ABT stock, worth $11.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

101,458

Previous 103,262 1.75%

Holding current value

$11.6 Million

Previous $10.7 Million 7.81%

% of portfolio

0.58%

Previous 0.56%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$100.07 - $118.13 $180,526 - $213,106	-1,804 Reduced 1.75%	101,458 $11.6 Million
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $55,502 - $61,954	551 Added 0.54%	103,262 $10.7 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $176,108 - $194,503	-1,608 Reduced 1.54%	102,711 $11.7 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $156,299 - $191,323	-1,733 Reduced 1.63%	104,319 $11.5 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $308,944 - $370,681	-3,234 Reduced 2.96%	106,052 $10.3 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $512,365 - $570,882	-5,084 Reduced 4.45%	109,286 $11.9 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $30,510 - $35,913	315 Added 0.28%	114,370 $11.6 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $270,445 - $317,274	2,845 Added 2.56%	114,055 $12.5 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $115,241 - $133,427	1,191 Added 1.08%	111,210 $10.8 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $100,538 - $121,519	-985 Reduced 0.89%	110,019 $12 Million
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $179,125 - $218,431	1,571 Added 1.44%	111,004 $13.1 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $95,081 - $116,421	823 Added 0.76%	109,433 $15.4 Million
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $264,351 - $292,449	2,266 Added 2.13%	108,610 $12.8 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $201,001 - $236,607	1,900 Added 1.82%	106,344 $12.3 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $123,098 - $145,028	1,131 Added 1.09%	104,444 $12.5 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $93,450 - $101,833	-890 Reduced 0.85%	103,313 $11.3 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $151,022 - $183,405	1,648 Added 1.61%	104,203 $11.3 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $526,725 - $674,142	6,879 Added 7.19%	102,555 $9.38 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $172,880 - $252,798	2,752 Added 2.96%	95,676 $7.55 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $29,205 - $32,512	372 Added 0.4%	92,924 $8.07 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $182,830 - $198,245	2,234 Added 2.47%	92,552 $7.74 Million
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $129,872 - $151,470	1,782 Added 2.01%	90,318 $7.6 Million
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $173,562 - $209,837	-2,621 Reduced 2.88%	88,536 $7.08 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $20,061 - $22,726	-306 Reduced 0.33%	91,157 $6.59 Million
Q3 2018 Nov 08, 2018	BUY	$60.81 - $73.36 $73,823 - $89,059	1,214 Added 1.35%	91,463 $6.71 Million
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $73,632 - $81,267	1,279 Added 1.44%	90,249 $5.5 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $31,736 - $35,881	-564 Reduced 0.63%	88,970 $5.33 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $188,899 - $202,236	3,519 Added 4.09%	89,534 $5.11 Million
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $4.13 Million - $4.61 Million	86,015	86,015 $4.59 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Account

Linscomb & Williams, Inc. Abbott Laboratories Transaction History